BGMD's logo.
Ticker Symbol: BGMD

BG Medicine Inc

Exchange: OTC MARKETS Country: US Currency: USD Asset Type: Common Stock CIK:0001407038

Company Profile

bg medicine, inc. (nasdaq:bgmd), the developer of the bgm galectin-3® test, is focused on the development and delivery of diagnostic solutions to aid in the clinical management of heart failure and related disorders. for additional information about bg medicine, heart failure and galectin-3 testing, please visit www.bg-medicine.com.

Sector: Professional, Scientific, and Technical Services
Industry: Testing Laboratories
Standard Industrial Classification Code (SIC code): 0
Address: 124 Washington St Ste 101
CEO: Paul Sohmer
Tags:
  • Biotechnology
  • Health Technology
  • Pharmaceuticals: Major
  • Professional, Scientific, and Technical Services
  • Testing Laboratories

Pricing

Last Updated: December 31, 1969 07:00 PM EST
Previous Close: -
Change: - ( 0.00%)
Days Range: $0.00 - $0.00
Beta: -
52wk. High: $0.02
52wk. Low: $0.00
Ytd. Change -66.67%
50 Day Moving Average: -
200 Day Moving Average: $0.00
Shares Outstanding: 11374360

Valuation

Market Cap: $1,137.00
PE Ratio: -
EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A